Die Bedeutung des Wnt/β-Catenin-Signalwegs für die Radiotherapieresistenz des Rektumkarzinoms sowie von Normalgewebe am Beispiel von RPE-1-Zellen

Möller, Janneke

dc.contributor.advisor	Grade, Marian PD Dr.
dc.contributor.author	Möller, Janneke
dc.date.accessioned	2020-09-22T11:31:14Z
dc.date.available	2020-11-10T23:50:02Z
dc.date.issued	2020-09-22
dc.identifier.uri	http://hdl.handle.net/21.11130/00-1735-0000-0005-1485-E
dc.identifier.uri	http://dx.doi.org/10.53846/goediss-8190
dc.language.iso	deu	de
dc.rights.uri	http://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subject.ddc	610	de
dc.title	Die Bedeutung des Wnt/β-Catenin-Signalwegs für die Radiotherapieresistenz des Rektumkarzinoms sowie von Normalgewebe am Beispiel von RPE-1-Zellen	de
dc.type	doctoralThesis	de
dc.title.translated	The impact of the Wnt/β-catenin pathway on the radiotherapy resistance in rectal cancer and normal tissue using the example of RPE-1 cells	de
dc.contributor.referee	Grade, Marian PD Dr.
dc.date.examination	2020-11-03
dc.description.abstracteng	Colorectal cancer is one of the most common cancers worldwide. The standard treatment for locally advanced rectal cancer is neoadjuvant chemoradiotherapy followed by surgery. However, the response to chemoradiotherapy is highly heterogeneous and ranges from complete response to complete resistance. Thus, patients with a priori resistant tumors receive a costly treatment and are exposed to its potential side-effects without benefit. Hence, it seems sensible to individualize the treatment. Therefore, a better understanding of the underlying mechanisms of the treatment resistance is strongly needed. Gene expression analyses showed an upregulation of the transcription factor TCF7L2 in primary rectal cancers that are resistant to chemoradiotherapy. TCF7L2 plays a central role in the Wnt/β- catenin pathway. Kendziorra et al. suggested that silencing of TCF7L2 in the resistant colorectal cancer cell lines SW480 and SW837 results in sensitization to radiotherapy. The aim of this thesis is to investigate the influence of the Wnt/β-catenin pathway on the (chemo-) radiotherapy resistance in the normal cell line RPE-1. Therefore, the Wnt/β-catenin pathway was stimulated both externally using the ligand Wnt3a as well as internally via overexpression of mutated β-catenin (S33Y). Subsequently, the sensitivity of the cells to (chemo-) radiotherapy was determined. It was shown that both types of stimulation produce significant increase of (chemo-) radiotherapy resistance in RPE-1 cells. Thus, our results show that the activity of the Wnt/β-catenin pathway affects the (chemo-) radiotherapy resistance in malignant and non-malignant cells. Consequently, the specific manipulation of the Wnt/β-catenin pathway appears to be a promising approach in cancer treatment.	de
dc.contributor.coReferee	Kube, Dieter Prof. Dr.
dc.subject.eng	treatment resistance	de
dc.subject.eng	colorectal cancer	de
dc.subject.eng	radiotherapy	de
dc.subject.eng	Wnt/β-catenin signaling	de
dc.subject.eng	RPE-1 cells	de
dc.identifier.urn	urn:nbn:de:gbv:7-21.11130/00-1735-0000-0005-1485-E-5
dc.affiliation.institute	Medizinische Fakultät	de
dc.subject.gokfull	Medizin (PPN619874732)	de
dc.description.embargoed	2020-11-10
dc.identifier.ppn	1733581650

Dateien

Name:eDiss_Janneke_Möller.pdf

Größe:2.542Mb

Format:PDF

Öffnen

Name:: eDiss_Janneke_Möller.pdf
Größe:: 2.542Mb
Format:: PDF

Öffnen

Das Dokument erscheint in:

Human- und Zahnmedizin [2877]

Zur Kurzanzeige